180 Life Sciences Corp. - Likuiditas cepet ATNF

The current market value of ETHZilla Corporation (ATNF) shown on this chart is fixed at 9.71. The business relies on anti-TNF therapy patents to combat fibrosis, anticipating royalties from pharmaceutical behemoths. Simultaneously, the company is expanding into the blockchain sector and online gambling to penetrate the crypto market. The brand is currently undergoing an image rebranding phase, gradually restoring its authority among scientists and attracting investor attention.

The long-term sustainability of ETHZilla Corporation (ATNF) is determined by its ability to promptly settle short-term obligations without liquidating inventory. This indicator measures the ratio of cash and accounts receivable to current liabilities, excluding illiquid assets. By analyzing the quick liquidity snapshot, an investor assesses the risk of cash flow gaps. For ETHZilla Corporation (ATNF), this metric is critical, as the radical shift in business model toward IT platforms has created a zone of high uncertainty.